●  SunHour Capital · FDA 510(k) Clearance Report

Every new FDA 510(k) clearance, every month.

A clean monthly list of newly cleared medical devices, pulled from public openFDA data and grouped by specialty, so you can spot new products, new manufacturers and new sales opportunities before everyone else gets around to it.

278
clearances in the sample issue
19
FDA review panels covered
248
distinct applicant companies
Sep 12 – Oct 11
2026 sample window

01  What's inside

One month of clearances, organized for action.

Grouped by specialty

Clearances sorted by FDA review panel: radiology, orthopedic, cardiovascular, dental, general surgery and more.

Who cleared what

Device name, K number, product code, device class, regulation number and decision date for each clearance.

Applicant details

Applicant company, city, state and country as filed, plus the contact name listed on the FDA record.

Link to the source

Every row links straight to its FDA 510(k) database record so you can verify and read the summary.

Who should care

A short note on which buyers, suppliers or partners each clearance is most relevant to.

Delivered by email

Monthly PDF digest on every plan; Pro and Team add the full CSV spreadsheet and more.

02  Who it's for

Built for people who sell to, build for, or invest in medtech.

  • Medtech sales reps

    Find newly cleared devices and the companies behind them in your territory and specialty.

  • Distributors

    Spot new products, especially from overseas manufacturers, that may need US distribution.

  • Contract manufacturers

    See which companies just cleared devices and may be scaling production.

  • Regulatory consultants

    Track product codes and predicate activity in the areas where you advise clients.

  • Investors

    Follow clearance activity by company and specialty as a signal of commercial progress.

03  Sample preview

Real rows from the sample issue.

Download the free sample PDF ↓

The six most recent of 278 clearances decided Sep 12 – Oct 11, 2026. The full sample is a 28-page PDF digest grouped by specialty.

DecisionK numberDeviceCodePanelApplicantCountry
2026-10-11K253717Helo™ ReturnCACAnesthesiologyEndovascular Engineering, Inc.US
2026-10-09K262068Khelix Magnetic Sensor Electrophysiology Catheter (SS1-*-*-MAG)DRFCardiovascularCathRx, Ltd.AU
2026-10-09K261649Excelsior Reach MicrocatheterQJPCardiovascularStryker NeurovascularUS
2026-10-09K260687VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChe…NBWClinical ChemistryVivachek Biotech (Hangzhou) Co., Ltd.CN
2026-10-09K260096Wishbone HAENPMDentalWishbone SABE
2026-10-09K260913CMF Titanium SplintsDZJDentalMaterialise NVBE

Source: openFDA device 510(k) endpoint. Scroll the table sideways on small screens.

04  Pricing

Simple monthly plans. Cancel anytime.

Digest

$29/mo

The monthly report, ready to read.

  • Monthly PDF digest
  • Clearances grouped by specialty
  • Links to every FDA record
  • Delivered by email
Subscribe to Digest
Most popular

Pro

$99/mo

The data you can work with.

  • Everything in Digest
  • Full spreadsheet (CSV) every month
  • Alerts for your chosen specialties and product codes
  • Company websites
Subscribe to Pro

Team

$249/mo

For teams that live in the data.

  • Everything in Pro
  • Full clearance history
  • Google Sheets sync
  • Multiple users
Subscribe to Team

Secure checkout by Stripe. Prices in USD, billed monthly.

05  FAQ

Questions

Where does the data come from?

From the U.S. FDA's public openFDA device 510(k) dataset. We organize, group and annotate it; every row links back to the official FDA record so you can verify it.

How is the report delivered?

By email each month. Digest subscribers get the PDF; Pro and Team subscribers also get the CSV spreadsheet.

Can I cancel anytime?

Yes. Subscriptions are billed monthly through Stripe and you can cancel at any time. You keep access through the end of the period you paid for.

What period does each issue cover?

Roughly one month of FDA decision dates. The free sample covers clearances decided Sep 12 to Oct 11, 2026.

Is this regulatory or investment advice?

No. It's an organized summary of public FDA data for research and prospecting. Always confirm details against the FDA record.